The evolving field of biodefence: therapeutic developments and diagnostics
- 1 April 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 4 (4) , 281-296
- https://doi.org/10.1038/nrd1694
Abstract
The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.Keywords
This publication has 212 references indexed in Scilit:
- Ebola virus: from discovery to vaccineNature Reviews Immunology, 2003
- A novel recombinant vaccine which protects mice against ricin intoxicationVaccine, 2002
- A Dominant Negative Mutant of Bacillus anthracisProtective Antigen Inhibits Anthrax Toxin Action in VivoJournal of Biological Chemistry, 2001
- Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of AnthraxScience, 2001
- High affinity T cell receptors from yeast display libraries block T cell activation by superantigens11Edited by I. A. WilsonJournal of Molecular Biology, 2001
- Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine/Threonine Phosphorylation of MAPKs in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1998
- Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activityFEBS Letters, 1998
- Structure-based identification of a ricin inhibitorJournal of Molecular Biology, 1997
- Proteolysis of synthetic peptides by type A botulinum neurotoxinProtein Journal, 1995
- X-ray analysis of substrate analogs in the ricin A-chain active siteJournal of Molecular Biology, 1992